Frequency of Allergic or Hematologic Adverse Reactions to Ticlopidine Among Patients With Allergic or Hematologic Adverse Reactions to Clopidogrel-Reference-Cited by-同舟云学术

Frequency of Allergic or Hematologic Adverse Reactions to Ticlopidine Among Patients With Allergic or Hematologic Adverse Reactions to Clopidogrel

Published:2009-08 Issue:4 Volume:2 Page:348-351
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Lokhandwala Juzar O.¹,Best Patricia J.M.¹,Butterfield Joseph H.¹,Skelding Kimberly A.¹,Scott Thomas¹,Blankenship James C.¹,Buckley Jeremy W.¹,Berger Peter B.¹

Affiliation:

1. From the Department of Cardiology (J.O.L., K.A.S., T.S., J.C.B., J.W.B., P.B.B.) and Center for Clinical Studies (P.B.B.), Geisinger Medical Center, Danville, Pa; and Divisions of Cardiovascular Diseases (P.J.M.B.) and Allergic Diseases (J.H.B.), Mayo Clinic, Rochester, Minn.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents

2. Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents

3. Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents

4. The Antiplatelet Effects of Ticlopidine and Clopidogrel

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulants;Cutaneous Drug Hypersensitivity;2022

2. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs;The Journal of Allergy and Clinical Immunology: In Practice;2020-10

3. Use of Alternative Antiplatelet Agents for Clopidogrel Hypersensitivity;Current Vascular Pharmacology;2019-01-09

4. Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach;Current Vascular Pharmacology;2019-01-09

5. Managing Clopidogrel Hypersensitivity without Interrupting Therapy: The Toronto Approach;Current Vascular Pharmacology;2019-01-09